1. Home
  2. ELMD vs AGEN Comparison

ELMD vs AGEN Comparison

Compare ELMD & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electromed Inc.

ELMD

Electromed Inc.

HOLD

Current Price

$39.45

Market Cap

326.9M

Sector

Health Care

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$8.09

Market Cap

274.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELMD
AGEN
Founded
1992
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
326.9M
274.8M
IPO Year
2010
1999

Fundamental Metrics

Financial Performance
Metric
ELMD
AGEN
Price
$39.45
$8.09
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$36.00
$14.50
AVG Volume (30 Days)
48.1K
1.6M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
46.55
100.00
EPS
0.91
0.96
Revenue
$54,716,000.00
$42,877,086.00
Revenue This Year
$15.59
$107.63
Revenue Next Year
$11.51
N/A
P/E Ratio
$43.96
$7.80
Revenue Growth
13.83
89.95
52 Week Low
$19.93
$2.71
52 Week High
$47.40
$8.85

Technical Indicators

Market Signals
Indicator
ELMD
AGEN
Relative Strength Index (RSI) 44.85 63.35
Support Level $35.61 $3.04
Resistance Level $43.61 $8.78
Average True Range (ATR) 1.41 0.69
MACD -0.22 -0.05
Stochastic Oscillator 19.53 68.27

Price Performance

Historical Comparison
ELMD
AGEN

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: